FIELD: organic chemistry, biochemistry, medicine, pharmacy. SUBSTANCE: invention relates to bicyclic tetrahydropyrazole- -pyridines of the formula (I) where R1 is C1-3-alkyl; X - oxygen atom or two hydrogen atoms; R2 is C1-4-alkyl, indalyl, C3-7-cycloalkyl or the group of the formula (II) ; a = 1 or 2; b and c = 0 or 1; R4 - H, C1-5-alkyl, alkoxyl, C3-6-cyclo- -alkoxyl, halogen atom, CF3, CO2R6, CONR6R7, NR6R7; R6, R7 - H or C1-4-alkyl; Z is SO; Y is C1-5-alkylene; R3 has values indicated for R2 and methylenecyclopropyl at condition that R2 and R3 can not mean simultaneously methyl, or their pharmaceutically acceptable salts and a pharmaceutical composition based on said that inhibit activity of phosphodiesterase of type-IV and production of tumor necrosis factor. EFFECT: enhanced effectiveness of compounds and composition as inhibitors of phosphodiesterase, improved method of treatment. 8 cl, 7 tbl, 39 ex
Title | Year | Author | Number |
---|---|---|---|
TRICYCLIC 5,6-DIHYDRO-9H-PYRAZOLO-[3,4-C]-1,2,4-TRIAZOLO- -[4,3-A]-PYRIDINES, METHOD OF INHIBITION OF ACTIVITY OF PHOSPHODIESTERASE TYPE IV AND METHOD OF INHIBITION OF TUMOR-SPECIFIC NECROSIS FACTOR PRODUCING | 1996 |
|
RU2161158C2 |
SUBSTITUTED PYRAZOLES, PHARMACEUTICAL COMPOSITION BASED ON THEREOF, USING PHARMACEUTICAL COMPOSITION AND METHOD FOR INHIBITION OF CATHEPSIN S ACTIVITY | 2001 |
|
RU2317988C2 |
PYRAZOLOPYRIMIDINES AND THEIR PHARMACEUTICALLY ACCEPTABLE SALTS | 1993 |
|
RU2124016C1 |
HETEROCYCLIC COMPOUND, PHARMACEUTICAL COMPOSITION AND METHOD OF INHIBITION OF 5-LIPOXYGENASE ACTIVITY | 1995 |
|
RU2136666C1 |
PRODRUGS OF CONJUGATED BICYCLIC C5aR ANTAGONISTS | 2019 |
|
RU2794327C2 |
DERIVATIVES OF ARYLSULFONYLAMINOHYDROXAMIC ACID, METHOD OF THEIR SYNTHESIS, PHARMACEUTICAL COMPOSITION, METHOD OF INHIBITION OF MATRIX METALLOPROTEINASES AND METHOD OF PATIENT TREATMENT | 1996 |
|
RU2145597C1 |
AMINOSUBSTITUTED PYRAZOLES AND INTERMEDIATE AMINO SUBSTITUTED PYRAZINES | 1993 |
|
RU2142455C1 |
SUBSTITUTED PYRAZOLES | 2001 |
|
RU2286343C2 |
SUBSTITUTED PYRAZOLES, PHARMACEUTICAL COMPOSITION BASED ON SAID, METHOD OF PATIENT TREATMENT, INTERMEDIATE COMPOUND | 1993 |
|
RU2130453C1 |
METHOD FOR TREATMENT OF ALLERGY BY USING SUBSTITUTED PYRAZOLES | 2001 |
|
RU2290179C2 |
Authors
Dates
1999-06-20—Published
1994-06-16—Filed